Clinicians from Fox Chase Cancer Center at Temple University Health share their highlights from the Society of Urologic ...
The current melanoma staging system does not always reflect actual survival outcomes. In some cases, patients with thick but ...
Today, Takeda announced positive topline results from 2 pivotal phase 3 trials of zasocitinib (TAK-279; Takeda), demonstrating superiority over placebo across key efficacy end points in adults with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback